Browse diseases

…ohort, yielding an HR of 1.10 (95% CI 0.98 to 1.24). The HR for Alzheimer’s disease was 1.16 (95% CI 0.94 to 1.43). Among individuals with overweig…

…sk, while dcLVA shows early promise in stabilizing cognition in Alzheimer’s disease. The consistent direction of effect and favorable safety profil…

…Abstract Alzheimer’s disease, the leading cause of dementia, is a multifactorial disorder in…

…cy over metformin in mitigating dementia risk, particularly for AD (AHR 0.88) and non-VaDs (AHR 0.75), likely through distinct neu…

…a risk differed by dementia subtype, with vascular dementia and Alzheimer’s disease being more prevalent among low-income men and low-income women,…

…Background Anti-amyloid therapies for Alzheimer’s disease (AD) require efficient patient selection. The Clinical Dementia…

…rolled trials of patients with mild cognitive impairment due to Alzheimer’s disease (AD) or mild AD treated with mAB or AChEI for at least 6 months…

…‘not significant’.Results The ARB group was less likely to have Alzheimer’s disease (AD) pathology compared with the ACEI group: Thal amyloid (adju…

… coherence tomography (OCT) could facilitate early detection of Alzheimer’s disease (AD), complementing current invasive or costly diagnostic metho…

…Rs were significantly elevated for all cancers combined and for stomach cancer, colorectal cancer, prostate cancer and haematopoietic malignan…

…on RR 5.07 (95% CI: 2.92-8.82). Similarly, an increased risk of Alzheimer’s disease was reported in a study in Sweden containing around 6,000 forme…

…s, webinars and key stakeholders to inform policy, research and AD management strategies.PROSPERO registration number CRD 42025104…